CENTOGENE GmbH: CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Assay for Individuals Without Symptoms or Other Reasons to Suspect COVID-19

Written by Petra Hegmann on 19th October 2020. Posted in Client News.

• Previous
• Next